Home > About us > News > Content
​China invention patent of Prof GJ Zhang's team regarding reverse of tamoxifen resistance granted
Pubdate: 2021/01/26 Hits:

On Jan 13, the State Intellectual Property Office of China granted Xiang’an Hospital of Xiamen University an invention patent "hTERT-miR-221/222 sponge and its application in the reversal of tamoxifen resistance in breast cancer (201910364686.5)" with the inventors GJ Zhang, M Chen, YX Ouyang and J Feng.

 

 

Currently, tamoxifen-resistant breast cancer patients have significantly higher recurrence and mortality rates due to limited treatment options. Above invention includes a specific compound targeting breast cancer cell’s miR-221/222 which enhances the tumor specificity and efficacy in gene therapy followed by reverse of tamoxifen resistance and therefore provides a potential availability for clinical application.

Copyrights © 2020 Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer / The Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen. All rights reserved. Republication or redistribution of material on this website is prohibited without the prior written consent of Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer / The Key Laboratory for Endocrine-Related Cancer Precision Medicine of Xiamen.

The information and contents on this website are provided for general information purposes and references only, and on the understanding that no any medical/academic advice or recommendation is being rendered or given. All information and contents are not warranted to be absolutely correct, accurate, complete or up-to-date. All materials and functions are not warranted to be uninterrupted, error-free or virus/harmful element-free. We are entitled to delete, suspend or edit any information (including but not limited to service details and charges), contents and materials and stop any functions from time to time without prior notice or giving any reasons. We accept NO responsibility for any losses, damages or misunderstandings incurred for any causes whatsoever in relation to or as a result of the use of this website.